secukinumab
0 sources
secukinumab
Summary
secukinumab is a type of chemical entity[1]. secukinumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (135 views/month).[2]
Key Facts
- secukinumab's instance of is recorded as type of chemical entity[3].
- secukinumab's CAS Registry Number is recorded as 875356-43-7[4].
- secukinumab's ATC code is recorded as L04AC10[5].
- secukinumab's chemical formula is recorded as C₆₅₈₄H₁₀₁₃₄N₁₇₅₄O₂₀₄₂S₄₄[6].
- secukinumab's subclass of is recorded as chemical compound[7].
- secukinumab's has use is recorded as medication[8].
- secukinumab's Commons category is recorded as Secukinumab[9].
- secukinumab's MeSH descriptor ID is recorded as C555450[10].
- secukinumab's ChEMBL ID is recorded as CHEMBL1743068[11].
- secukinumab's Guide to Pharmacology Ligand ID is recorded as 8078[12].
- secukinumab's Freebase ID is recorded as /m/0h560sz[13].
- secukinumab's UNII is recorded as DLG4EML025[14].
- secukinumab's KEGG ID is recorded as D09967[15].
- secukinumab's DrugBank ID is recorded as DB09029[16].
- secukinumab's has characteristic is recorded as biopharmaceutical[17].
- secukinumab's side effect is recorded as eczema[18].
- secukinumab's NDF-RT ID is recorded as N0000191427[19].
- secukinumab's medical condition treated is recorded as ankylosing spondylitis[20].
- secukinumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'secukinumab'}[21].
- secukinumab's subject has role is recorded as monoclonal antibody[22].
- secukinumab's UMLS CUI is recorded as C3179548[23].
- secukinumab's RxNorm CUI is recorded as 1599788[24].
- secukinumab's World Health Organisation international non-proprietary name numeric ID is recorded as 9182[25].
- secukinumab's Quora topic ID is recorded as Secukinumab[26].
- secukinumab's pregnancy category is recorded as US pregnancy category B[27].
Why It Matters
secukinumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (135 views/month).[2] secukinumab has Wikipedia articles in 18 language editions, a strong signal of global cultural recognition.[28] secukinumab is known by 5 alternative names across languages and contexts.[29]